Black Rock Inc. Uro Gen Pharma Ltd. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Black Rock Inc. holds 1,716,813 shares of URGN stock, worth $26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,716,813

Previous 1,719,304 0.14%

Holding current value

$26 Million

Previous $25.8 Million 0.14%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$13.81 - $19.33 $34,400 - $48,151	-2,491 Reduced 0.14%	1,716,813 $25.8 Million
Q4 2023 Feb 13, 2024	BUY	$10.87 - $15.93 $5.67 Million - $8.31 Million	521,657 Added 43.56%	1,719,304 $25.8 Million
Q3 2023 Nov 13, 2023	BUY	$8.84 - $22.64 $881,622 - $2.26 Million	99,731 Added 9.08%	1,197,647 $16.8 Million
Q2 2023 Aug 11, 2023	BUY	$8.75 - $14.29 $7.12 Million - $11.6 Million	813,377 Added 285.86%	1,097,916 $11.4 Million
Q1 2023 May 12, 2023	SELL	$7.99 - $11.02 $517,200 - $713,335	-64,731 Reduced 18.53%	284,539 $2.63 Million

Q4 2022 Feb 13, 2023	BUY	$7.55 - $11.9 $33,914 - $53,454	4,492 Added 1.3%	349,270 $3.1 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $9.41 $31,478 - $41,084	4,366 Added 1.28%	344,778 $2.87 Million
Q2 2022 Aug 12, 2022	SELL	$5.12 - $8.74 $6.97 Million - $11.9 Million	-1,360,364 Reduced 79.98%	340,412 $2.79 Million
Q1 2022 May 12, 2022	SELL	$5.92 - $9.73 $161,722 - $265,804	-27,318 Reduced 1.58%	1,700,776 $14.8 Million
Q4 2021 Feb 10, 2022	BUY	$9.03 - $19.13 $143,315 - $303,612	15,871 Added 0.93%	1,728,094 $16.4 Million
Q3 2021 Nov 09, 2021	SELL	$14.31 - $18.39 $212,016 - $272,466	-14,816 Reduced 0.86%	1,712,223 $28.8 Million
Q2 2021 Aug 11, 2021	BUY	$15.2 - $20.94 $26.3 Million - $36.2 Million	1,727,039 New	1,727,039 $26.4 Million

Others Institutions Holding URGN

# of Institutions

113

Shares Held

24M

Call Options Held

46.9K

Put Options Held

44.3K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $344M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account